Back

Addiction Potential of Combustible Menthol Cigarette Alternatives: A Randomized Crossover Trial

Wagener, T. L.; Mehta, T.; Hinton, A.; Schulz, J.; Erath, T.; Tidey, J. W.; Villanti, A. C.

2022-06-17 addiction medicine
10.1101/2022.06.16.22276504 medRxiv
Show abstract

IntroductionThe FDA announced its intention to issue proposed product standards banning menthol as a characterizing flavor in cigarettes and cigars. The public health benefits of these product standards may be attenuated by the role of plausible substitutes in the marketplace. Therefore, the present study examined the addiction potential of plausible combustible menthol alternatives compared to usual brand menthol cigarettes (UBMC). MethodsEighty adult menthol cigarette smokers completed four visits, smoking their UBMC at the first session and 3 menthol cigarette alternatives in random order at the subsequent visits: 1) a pre-assembled menthol roll-your-own cigarette using menthol pipe tobacco and mentholated cigarette tube (mRYO), 2) a menthol filtered little cigar (mFLC), and 3) a non-menthol cigarette (NMC). Measures of smoking topography, exhaled carbon monoxide (CO), craving and withdrawal, subjective effects, and behavioral economic demand indices were assessed. ResultsCompared to UBMC, menthol cigarette alternatives resulted in similar topography and CO exposure but significantly lower levels of positive subjective experience and behavioral economic demand indices. Among the alternative products, participants reported the highest level of positive subjective experience and higher demand for mRYO, compared with mFLC and NMC. Similarly, participants were significantly more likely to want to try again, purchase, and use the mRYO product regularly compared with mFLC and NMC. Conclusions and RelevancemRYO cigarettes were the most highly rated cigarette alternative among study products, suggesting their potential appeal as a menthol cigarette substitute and needed inclusion of menthol pipe tobacco and cigarette tubes in FDAs proposed ban. What is already known on this topicMenthol cigarettes are associated with increased smoking initiation, higher nicotine dependence, and decreased adult cessation, particularly among vulnerable populations. To address this public health issue, the FDA announced in April 2021 its intention to issue product standards banning menthol as a characterizing flavor in both cigarettes and cigars within a year. However, the public health benefits of these product standards may be attenuated by the role of plausible substitutes available in the marketplace What this study addsIn this randomized cross-over design study that included 80 adult menthol cigarette smokers, each of the alternative products demonstrated the ability to significantly reduce nicotine craving and withdrawal symptoms, but the combination of mentholated pipe tobacco and tubes in a menthol roll-your-own cigarette, resulted in the highest behavioral economic demand and positive subjective experience. How this study may affect policyTo maximize the benefits of a menthol cigarette ban, restrictions should extend to plausible substitutes, particularly menthol pipe tobacco and cigarette tubes.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Nicotine & Tobacco Research
11 papers in training set
Top 0.1%
27.1%
2
JAMA Network Open
127 papers in training set
Top 0.1%
10.9%
3
BMJ Open
554 papers in training set
Top 3%
6.7%
4
PLOS ONE
4510 papers in training set
Top 26%
6.7%
50% of probability mass above
5
Addiction
25 papers in training set
Top 0.1%
6.7%
6
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
5.1%
7
Drug and Alcohol Dependence
37 papers in training set
Top 0.2%
5.1%
8
International Journal of Drug Policy
11 papers in training set
Top 0.1%
2.7%
9
Frontiers in Artificial Intelligence
18 papers in training set
Top 0.2%
2.2%
10
Frontiers in Psychiatry
83 papers in training set
Top 1%
2.2%
11
Preventive Medicine Reports
14 papers in training set
Top 0.1%
1.7%
12
Frontiers in Public Health
140 papers in training set
Top 5%
1.4%
13
American Journal of Preventive Medicine
11 papers in training set
Top 0.3%
1.4%
14
JAMA
17 papers in training set
Top 0.1%
1.3%
15
Frontiers in Psychology
49 papers in training set
Top 0.7%
1.3%
16
Addiction Neuroscience
17 papers in training set
Top 0.4%
1.3%
17
Thorax
32 papers in training set
Top 0.6%
1.2%
18
PLOS Global Public Health
293 papers in training set
Top 5%
1.2%
19
Brain Sciences
52 papers in training set
Top 1%
0.9%
20
Addiction Biology
47 papers in training set
Top 0.7%
0.8%
21
Alcohol
15 papers in training set
Top 0.2%
0.8%
22
Scientific Reports
3102 papers in training set
Top 78%
0.7%
23
Cells
232 papers in training set
Top 8%
0.5%
24
Pharmacology Research & Perspectives
11 papers in training set
Top 0.4%
0.5%
25
International Journal of Environmental Research and Public Health
124 papers in training set
Top 8%
0.5%